Campaign continues for cuts of average wholesale prices for drugs

Why This Topic Matters

The article explains federal payment policy issues that can affect practice revenue, overhead coverage, and participation in Medicare. It also highlights related administrative and claims-processing proposals that may influence how providers are paid and how the program is managed.

Article Sections

1. Medicare drug reimbursement debate

   Discusses the policy dispute over how Medicare pays for drugs administered in physicians’ offices and the broader concerns raised in testimony before Congress.

2. HCFA Reform

   Covers testimony on agency program management funding and suggestions for administrative changes affecting Medicare oversight.

3. User fees

   Summarizes discussion of a proposed fee related to certain paper Medicare claims and reactions from congressional leaders.

4. RBRVS

   Addresses testimony calling for review and updating of the physician payment valuation system.